Major Scope

  •  Lung Cancer
  •  Colorectal Cancer
  •  Pancreatic Cancer
  •  Breast Cancer
  •  Prostate Cancer
  •  Liver Cancer
  •  Leukemia
  •  Bladder Cancer
  •  Kidney Cancer
  •  Endometrial Cancer
  •  Oncology Case Reports
  •  Radiation Therapy

Abstract

Citation: Clin Oncol. 2019;4(1):1565.DOI: 10.25107/2474-1663-v4-id1565

Is Mycosis Fungoides Truly an Indolent Pathology?

Sabah Bazouti, Said Afqir, Nada Zizi, Siham Dikhaye

Department of Dermatology, Mohammed 6 University Hospital of Oujda – Medical School of Oujda, Mohammed the First University of Oujda, Morocco
Laboratory of Epidemiology, Clinical Research and Public Health, Medical School of Oujda, Mohammed the First University of Oujda, Morocco
Department of Oncology, Mohammed 6 University Hospital of Oujda – Medical School of Oujda, Mohammed the First University of Oujda, Morocco

*Correspondance to: Sabah Bazouti 

 PDF  Full Text Case Report | Open Access

Abstract:

The course of Mycosis Fungoides (MF) is indolent except when the transformation to a large T-cell lymphoma occurs. The diagnosis of transformed MF relies on the presence of more than 25% of large cells on biopsy of an MF lesion. Treatment of transformed MF is a major challenge as these patients have poor outcome. Here, we report a 40-year-old man presenting in an advanced stage of disease with nodules all over the body diagnosed as cutaneous CD30(−) large cell transformed MF of fatal evolution.

Keywords:

Cutaneous T-cell lymphomas; Transformed mycosis fungoides; Tumor stage; CD30-

Cite the Article:

Bazouti S, Afqir S, Zizi N, Dikhaye S. Is Mycosis Fungoides Truly an Indolent Pathology? Clin Oncol. 2019; 4: 1565.

Journal Basic Info

  • Impact Factor: 3.231**
  • H-Index: 11 
  • ISSN: 2474-1663
  • DOI: 10.25107/2474-1663
  • PubMed NLM ID: 101705590

Search Our Journal

Journal Indexed In

Articles in PubMed

NMR Metabolomics in Ionizing Radiation
 PubMed  PMC  PDF  Full Text
LINGO-1 is a New Therapy Target and Biomarker for Ewing Sarcoma
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Erlotinib Treatment Beyond Progression in EGFR Mutant Patients Who Have Responded to EGFR TKIs in Stage IIIB/IV NSCLC: An Open Label Randomized Trial
 Abstract  PDF  Full Text
The Expression and Relationship of Tc17 Cells and Interleukin-27 in Local and Systemic Environment of Nonsmall Cell Lung Cancer
 Abstract  PDF  Full Text
View More...